nonpregnant – Communicable Diseases Research

Characteristics and treatment of hospitalized pregnant women with Coronavirus Disease 2019, COVID-19

Research article

Published on 2022-11-012022-10-05
Journal: American journal of obstetrics & gynecology MFM
[Category] 임상, 치료법,

Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status-United States, 1 January 2020-25 December 2021

Article

Published on 2022-10-032022-11-16
Journal: Clinical Infectious Diseases: An Official Publicat
[Category] COVID19(2023년), SARS, 변종,

Outcomes of pregnant patients treated with REGEN-COV during the COVID-19 pandemic

Article

Published on 2022-09-012022-10-05
Journal: American journal of obstetrics & gynecology MFM
[Category] COVID19(2023년), SARS, 임상, 진단,

[키워드] administration Admission adverse events anaphylaxis Atlanta authorization benefit casirivimab and imdevimab Clinical course Clinical outcome Cohort cohort of patient COVID-19 COVID-19 illness COVID-19 pandemic COVID-19 therapeutics death drug Effect Efficacy eligible Emergency food groups high-risk population higher risk Hospital stay Hospitalization Hypothesis increased risk individual Infection instance intensive care less Maternal morbidity Memorial monoclonal antibodies monoclonal antibody morbidity and mortality need for oxygen Neonatal Neonatal morbidity no significant difference nonpregnant novel therapies offered outcome outcomes Oxygen requirement patients with SARS-CoV-2 pharmacologic treatment Placebo polymerase chain positive Pregnancy pregnant pregnant patient pregnant patients pregnant population receive reduce reduced REGEN-COV released resolved Respiratory illness retrospective cohort study risk Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 viral load severe COVID-19 severe disease Shortness of breath shown side statistically significant difference Symptom tested therapy thought treated Treatment treatment guideline Trial trials ventilatory support were excluded worsening
[DOI] 10.1016/j.ajogmf.2022.100673 [Article Type] Article

Laboratory-Confirmed COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance – COVID-19-Associated Hospitalization Surveillance Network, 14 States, June 20, 2021-May 31, 2022

Article

Published on 2022-08-262022-11-16
Journal: Morbidity and Mortality Weekly Report
[Category] SARS, 변종,

An update on COVID-19 and pregnancy

Article

Published on 2022-02-012022-11-16
Journal: American journal of obstetrics and gynecology
[Category] COVID19(2023년), SARS, 치료기술,

[키워드] accumulating addition Administered adverse effect Affect age alteration angiotensin-converting enzyme 2 appear Cell center comparable Control COVID-19 COVID-19 vaccine death determine Effect Evidence extracorporeal membrane oxygenation fetal fetal death fetus Health Healthcare system improvement incidence increase information intensive care invasive ventilation lack lactating Maternal death Newborn nonpregnant outcome outcomes pandemic perinatal infection Placenta Pneumonia Pregnancy pregnant Preterm birth prevention reported reproductive risk factor SARS-CoV-2 SARS-CoV-2 entry SARS-COV-2 infection severe COVID-19 disease severe disease severity of COVID-19 Stillbirth Support Surveillance susceptibility the United State the vaccine transmembrane serine protease Transmission transmission of SARS-CoV-2 Vertical transmission. Viremia women
[DOI] 10.1016/j.ajog.2021.08.054 PMC 바로가기

An Unusual Presentation of COVID-19 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A) in a Pregnant Woman

Case Report

Published on 2022-01-072022-10-31
Journal: Case Reports in Obstetrics and Gynecology
[Category] COVID-19,

Pathophysiological and molecular considerations of viral and bacterial infections during maternal-fetal and -neonatal interactions of SARS-CoV-2, Zika, and Mycoplasma infectious diseases

SARS-CoV-2, Zika 및 Mycoplasma 전염병의 산모-태아 및 신생아 상호작용 중 바이러스 및 세균 감염의 병태생리학적 및 분자적 고려

Article

Published on 2022-01-012022-09-11
Journal: Biochimica et biophysica acta. Molecular basis of
[Category] MERS, SARS, 바이오마커, 진단,

[키워드] addition Admission age Anomaly Bacteria Bacterial infection Bacterial infections birth defects Case report case reports Case series caused cellular Characteristics children COVID-19 COVID-19 disease death disease disease severity during pregnancy elevated epidemiological data epidemiological studies Epidemiological study example fetus focus higher risk Hospitalized increase increased risk Infant Infants Infection Infectious disease intensive care intensive care unit admission Interaction macroscopic manifestation Maternal Maternal-fetal interphase mechanical ventilation mechanism microcephaly molecular mother Mycoplasma Neonate Neonates nonpregnant not increased Older outcomes pandemic Particular pathogen Pathogens pathophysiological physiological change Physiological changes Pregnancy pregnant women progression risk SARS-CoV-2 SARS-CoV-2 virus severe COVID-19 disease susceptibility susceptibility to infection susceptible the SARS-CoV-2 virus Viral virus infection viruses. with COVID-19 women Zika Zika virus infection ZIKV
[DOI] 10.1016/j.bbadis.2021.166285 PMC 바로가기 [Article Type] Article

Perspectives on administration of COVID-19 vaccine to pregnant and lactating women: a challenge for low- and middle-income countries

Research article

Published on 2021-11-012022-10-05
Journal: AJOG Global Reports
[Category] 변종, 임상,

Is the Immunization of Pregnant Women against COVID-19 Justified?

Review

Published on 2021-08-302022-10-28
Journal: Vaccines
[Category] COVID-19,

[키워드] Administered age antibody breastmilk carried children clinical trial coronavirus disease COVID-19 COVID-19 vaccine disease Efficacy evaluate fetal Follow-up immune response immunization increased risk Infants Infection Infectious disease initiated knowledge lactating women Maternal maternal immunization morbidity and mortality mother Mother-to-child transmission mRNA COVID-19 vaccine mRNA vaccine Neonates nonpregnant not different offer offspring passive immunity Placenta platform Pregnancy pregnant pregnant women preventive measure PROTECT Sample size severe disease subjects to define Tolerability transferred Vaccine virus variant women
[DOI] 10.3390/vaccines9090970 PMC 바로가기 [Article Type] Review

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season

Recommendations and Reports

Published on 2021-08-272022-10-30
Journal: MMWR Recommendations and Reports
[Category] COVID-19, Fulltext, MERS,

[키워드] Administered administration Admission Adults age allergic alleviate anaphylaxis anatomic sites approved Care cause caused CDC Cell children circulation Committee components concerning contraindication contraindications Control COVID-19 COVID-19 vaccine COVID-19 vaccines described document dose doses drug expected first dose food Guidance Health help hospitalizations identify inactivated include indications Influenza influenza vaccination influenza vaccine influenza vaccines information instance intensive care nonpregnant occur pandemic Practice Precaution pregnant women Prevalence prevention Quadrivalent receive recognize recombinant vaccines recommendation reduce reduction reduction in responsible routine SARS-CoV-2 season seasonal Seasonal influenza second second dose severity Stress Symptom the United State The United States the vaccine United States vaccination Vaccine Vaccines Victoria virus website
[DOI] 10.15585/mmwr.rr7005a1 PMC 바로가기 [Article Type] Recommendations and Reports